Your browser doesn't support javascript.
loading
Secondary Publication: Proposal for Points of Consideration for Pluripotent Stem Cell Culture.
Aoi, Takashi; Asaka, Isao; Akutsu, Hidenori; Ito, Yuzuru; Kataoka, Ken; Kanda, Yasunari; Kojima, Hajime; Sekino, Yuko; Suemori, Hirofumi; Nakagawa, Masato; Nakamura, Kazuaki; Nakamura, Yukio; Fujii, Makiko; Furue, Miho; Yamazaki, Daiju.
Afiliação
  • Aoi T; Division of Stem Cell Medicine, Graduate School of Medicine, Kobe University, Kobe, Hyogo, 650-0017, Japan.
  • Asaka I; Department of Fundamental Cell Technology, Center for iPS Cell Research and Application, Kyoto University, Kyoto, 606-8507, Japan.
  • Akutsu H; Center for Regenerative Medicine, National Center for Child Health and Development, Tokyo, 157-8538, Japan.
  • Ito Y; Faculty of Life and Environmental Sciences (Bioindustrial Sciences), University of Tsukuba, Tsukuba, Ibaraki, 305-8972, Japan.
  • Kataoka K; Department of Life Science, Faculty of Science, Okayama University of Science, Okayama, 700­0005, Japan.
  • Kanda Y; Division of Pharmacology, National Institute of Health Sciences, Kawasaki, Kanagawa, 210-0821, Japan.
  • Kojima H; Japanese Center for the Validation of Alternative Methods, National Institute of Health Sciences, Kawasaki, Kanagawa, 210-0821, Japan.
  • Sekino Y; Graduate School of Agricultural and Life Sciences, The University of Tokyo, Bunkyo-Ku, Tokyo, 113-8657, Japan.
  • Suemori H; Division of Clinical Basis for ES Cell Research, Institute for Frontier Life and Medical Sciences, Center for Human ES Cell Research, Kyoto University, 53 Kawahara-Cho, Shogoin, Sakyo-Ku, Kyoto, 606-8507, Japan.
  • Nakagawa M; Department of Life Science Frontiers, Center for iPS Cell Research and Application, Kyoto University, Kyoto, 606-8507, Japan.
  • Nakamura K; Department of Pharmacology, National Research Institute for Child Health and Development, Tokyo, 157-8535, Japan.
  • Nakamura Y; Cell Engineering Division, RIKEN BioResource Research Center, Tsukuba, 305-0074, Japan.
  • Fujii M; Department of Genomic Oncology and Oral Medicine, Graduate School of Biomedical and Health Science, Hiroshima University, Hiroshima, 834-8553, Japan.
  • Furue M; Laboratory of Stem Cell Cultures, National Institute of Biomedical Innovation, Health and Nutrition, Ibaraki, Osaka, 567-0085, Japan. mkfurue@gmail.com.
  • Yamazaki D; Cel-MiM, Ltd., Tokyo, Japan. mkfurue@gmail.com.
In Vitro Cell Dev Biol Anim ; 60(5): 563-568, 2024 May.
Article em En | MEDLINE | ID: mdl-38472720
ABSTRACT
Human pluripotent stem cells, such as human embryonic stem cells and human induced pluripotent stem cells, are used in basic research and various applied fields, including drug discovery and regenerative medicine. Stem cell technologies have developed rapidly in recent years, and the supply of culture materials has improved. This has facilitated the culture of human pluripotent stem cells and has enabled an increasing number of researchers and bioengineers to access this technology. At the same time, it is a challenge to share the basic concepts and techniques of this technology among researchers and technicians to ensure the reproducibility of research results. Human pluripotent stem cells differ from conventional somatic cells in many aspects, and many points need to be considered in their handling, even for those experienced in cell culture. Therefore, we have prepared this proposal, "Points of Consideration for Pluripotent Stem Cell Culture," to promote the effective use of human pluripotent stem cells. This proposal includes seven items to be considered and practices to be confirmed before using human pluripotent stem cells. These are laws/guidelines and consent/material transfer agreements, diversity of pluripotent stem cells, culture materials, thawing procedure, media exchange and cell passaging, freezing procedure, and culture management. We aim for the concept of these points of consideration to be shared by researchers and technicians involved in the cell culture of pluripotent stem cells. In this way, we hope the reliability of research using pluripotent stem cells can be improved, and cell culture technology will advance.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Técnicas de Cultura de Células / Células-Tronco Pluripotentes Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Técnicas de Cultura de Células / Células-Tronco Pluripotentes Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article